Revolution Medicines, Inc.
DE ˙ DB ˙ US76155X1000
135,15 € ↑1,10 (0,82%)
2026-06-03
AKTIENPREIS
SecurityDE:42Z / Revolution Medicines, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership89,742 shares
Latest Disclosed Value $ 8,727,410
Citigroup Inc ownership in 42Z / Revolution Medicines, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 89,742 shares of Revolution Medicines, Inc. (DE:42Z) valued at $7,358,844 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 45,702 shares of Revolution Medicines, Inc.. This represents a change in shares of 96.36% during the quarter. The current value of the position is $12,128,631 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (42Z) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:42Z / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F REVOLUTION MEDICINES COM 76155X100 89,742 44,040 96.36 8,727 139.75 0.0019
2026-02-13 2025-12-31 13F REVOLUTION MEDICINES COM 76155X100 45,702 28,402 164.17 3,640 351.05 0.0016
2025-11-10 2025-09-30 13F REVOLUTION MEDICINES COM 76155X100 17,300 -298,362 -94.52 808 -93.05 0.0004
2025-08-11 2025-06-30 13F REVOLUTION MEDICINES COM 76155X100 315,662 -293,726 -48.20 11,613 -46.10 0.0057
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES COM 76155X100 609,388 340,934 127.00 21,548 83.50 0.0110
2025-02-12 2024-12-31 13F REVOLUTION MEDICINES COM 76155X100 268,454 150,516 127.62 11,742 119.56 0.0070
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES COM 76155X100 117,938 59,571 102.06 5,348 136.11 0.0031
2024-08-12 2024-06-30 13F REVOLUTION MEDICINES COM 76155X100 58,367 -219,308 -78.98 2,265 -74.69 0.0015
2024-05-10 2024-03-31 13F REVOLUTION MEDICINES COM 76155X100 277,675 116,634 72.43 8,949 93.79 0.0059
2024-02-09 2023-12-31 13F REVOLUTION MEDICINES COM 76155X100 161,041 63,807 65.62 4,619 71.61 0.0033
2023-12-06 2023-09-30 13F/A-1 REVOLUTION MEDICINES COM 76155X100 97,234 -25,290 -20.64 2,691 -17.88 0.0020
2023-11-09 2023-09-30 13F REVOLUTION MEDICINES COM 76155X100 97,234 -25,290 2,691 0.0008
2023-08-10 2023-06-30 13F REVOLUTION MEDICINES COM 76155X100 122,524 -141,244 -53.55 3,278 -42.64 0.0021
2023-05-11 2023-03-31 13F REVOLUTION MEDICINES COM 76155X100 263,768 156,876 146.76 5,713 124.39 0.0040
2023-02-09 2022-12-31 13F REVOLUTION MEDICINES COM 76155X100 106,892 -138,253 -56.40 2,546 -47.33 0.0020
2022-11-10 2022-09-30 13F REVOLUTION MEDICINES COM 76155X100 245,145 135,598 123.78 4,834 126.42 0.0035
2022-08-10 2022-06-30 13F REVOLUTION MEDICINES COM 76155X100 109,547 80,987 283.57 2,135 192.87 0.0016
2022-05-12 2022-03-31 13F REVOLUTION MEDICINES COM 76155X100 28,560 -107,298 -78.98 729 -78.68 0.0004
2022-02-10 2021-12-31 13F REVOLUTION MEDICINES COM 76155X100 135,858 62,564 85.36 3,420 69.64 0.0018
2021-11-10 2021-09-30 13F REVOLUTION MEDICINES COM 76155X100 73,294 -49,023 -40.08 2,016 -48.07 0.0012
2021-08-10 2021-06-30 13F REVOLUTION MEDICINES COM 76155X100 122,317 31,314 34.41 3,882 -7.02 0.0023
2021-05-13 2021-03-31 13F REVOLUTION MEDICINES COM 76155X100 91,003 80,526 768.60 4,175 906.02 0.0027
2021-02-11 2020-12-31 13F REVOLUTION MEDICINES COM 76155X100 10,477 7,973 318.41 415 377.01 0.0002
2020-11-12 2020-09-30 13F REVOLUTION MEDICINES COM 76155X100 2,504 -1,648 -39.69 87 -33.59 0.0001
2020-08-12 2020-06-30 13F REVOLUTION MEDICINES COM 76155X100 4,152 29 0.70 131 45.56 0.0001
2020-05-12 2020-03-31 13F REVOLUTION MEDICINES COM 76155X100 4,123 4,123 90 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-10 2025-09-30 13F REVOLUTION MEDICINES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-11 2025-06-30 13F REVOLUTION MEDICINES COM Call 30,000 0.00 1,104 4.06 n/a n/a n/a
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES COM Call 30,000 1,061 n/a n/a n/a
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F REVOLUTION MEDICINES COM Call 62,600 198.10 2,430 259.32 n/a n/a n/a
2024-05-10 2024-03-31 13F REVOLUTION MEDICINES COM Call 21,000 -76.64 677 -73.78 n/a n/a n/a
2024-02-09 2023-12-31 13F REVOLUTION MEDICINES COM Call 89,900 2,578 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-10 2025-09-30 13F REVOLUTION MEDICINES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-11 2025-06-30 13F REVOLUTION MEDICINES COM Put 30,000 0.00 1,104 4.06 n/a n/a n/a
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES COM Put 30,000 1,061 n/a n/a n/a
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F REVOLUTION MEDICINES COM Put 29,900 1,160 n/a n/a n/a
2024-05-10 2024-03-31 13F REVOLUTION MEDICINES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-09 2023-12-31 13F REVOLUTION MEDICINES COM Put 25,000 717 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.